Kantonsspital Baselland
Liestal, Switzerland
7 recruiting
Showing 1–14 of 14 trials
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled536 locationsNCT06492616
Recruiting
Phase 2
Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
Metastatic NSCLC - Non-Small Cell Lung Cancer
Swiss Cancer Institute156 enrolled17 locationsNCT07020065
Recruiting
Phase 2
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
Triple-Negative Breast CancerTNBC - Triple-Negative Breast Cancer
Swiss Cancer Institute61 enrolled9 locationsNCT06358573
Recruiting
DESTINY Breast Respond HER2-low Europe
Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
Phase 3
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo740 enrolled243 locationsNCT05215340
Recruiting
Not Applicable
STOP? II: Testing of a Toolbox for Structured Communication in the Operating Room
Communication ResearchCommunication, Multidisciplinary
Insel Gruppe AG, University Hospital Bern400 enrolled13 locationsNCT05356962
Recruiting
Not Applicable
LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma
Non-hodgkin Lymphoma,B Cell
Swiss Cancer Institute64 enrolled14 locationsNCT06090162
Recruiting
Phase 3
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
High-grade Serous Ovarian Carcinoma (HGSOC)Fallopian Tube NeoplasmsOvarian Neoplasm Epithelial+3 more
Swiss GO Trial Group540 enrolled53 locationsNCT04111978
Recruiting
Swiss Primary Sclerosing Cholangitis Cohort Study
Primary Sclerosing Cholangitis (PSC)Cholangitis, SclerosingPSC
Fondazione Epatocentro Ticino120 enrolled21 locationsNCT03146936
Recruiting
Swiss Autoimmune Hepatitis Cohort Study
Autoimmune HepatitisHepatitis, Autoimmune
Fondazione Epatocentro Ticino500 enrolled20 locationsNCT03146884
Recruiting
Swiss Primary Biliary Cholangitis Cohort Study
Primary Biliary CholangitisPBC
Fondazione Epatocentro Ticino500 enrolled13 locationsNCT03146910
Recruiting
Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia
Thiazide-induced Hyponatremia (TIH)
University Hospital, Basel, Switzerland232 enrolled3 locationsNCT05542056
Recruiting
Phase 3
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris1,210 enrolled23 locationsNCT03819101
Recruiting
Phase 4
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
Advanced Solid Tumor
University Hospital, Basel, Switzerland100 enrolled4 locationsNCT06408688